Sun Pharma Q2 FY27: India Sales Up 17%, US Slips 8%
Sun Pharma’s Q2 FY27 revenue rose 11.9% to ₹16,198.7 crore on a 17.3% jump in India formulations, while US sales fell 8.3% and a one-time loss pulled reported profit down 32%.
ORGANON
Sun Pharma’s Q2 FY27 revenue rose 11.9% to ₹16,198.7 crore on a 17.3% jump in India formulations, while US sales fell 8.3% and a one-time loss pulled reported profit down 32%.
